A

Annovis Bio, Inc.

7 employees

Annovis Bio develops novel treatments for Alzheimer’s disease, Parkinson’s disease, and other neurodegenerative disorders.

Basic info

Industry

biotechnology research

Sectors

Biotechnology

APP

Axonal Transport

Alzheimer’s in Down Syndrome

tau

aSYN

APP/Ab (APP)

Alzheimer’s

Parkinson’s

neurotoxic proteins

Traumatic Brain Injury

Neurodegeneration

Developer Platform

Therapeutics

tau/phospho-tau

a-Synuclein (a-SYN)

Date founded

2008

Funding rounds raised

Total raised

$5.7M

from 7 investors over 7 rounds

A

Annovis Bio, Inc. raised $100K on January 31, 2020

Investors: Robin Hood Ventures

A

Annovis Bio, Inc. raised $800K on October 27, 2016

Investors: Robin Hood Ventures

A

Annovis Bio, Inc. raised $5.7M on May 26, 2015

Investors: Robin Hood Ventures, Delaware Crossing Investor Group and Keiretsu Forum / Capital

A

Annovis Bio, Inc. raised $350K on June 20, 2013

Investors: BioAdvance

A

Annovis Bio, Inc. raised $706K on April 26, 2010